SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is rallying dramatically, fueled by an AI licensing deal in Africa and a palpable short squeeze dynamic amplified by its low float. Community sentiment is overwhelmingly bullish, with traders celebrating significant gains and anticipating further upward movement as short positions face intense pressure within the red-hot AI sector.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is garnering significant attention as a crucial player in the critical minerals sector, driven by strategic operational expansions and notable increases in institutional holdings. The community is actively discussing the company's unique role as the sole integrated antimony producer outside of China and Russia, anticipating further government partnerships or investments. This focus on domestic critical mineral supply chains, vital for national security, is fostering strong bullish sentiment and expectations of continued growth.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is a trending topic amidst intense debate over the competitive landscape and regulatory environment for online betting. While the community discusses pressure from emerging prediction markets and NCAA calls for betting restrictions, a recent Massachusetts injunction against a prediction markets sports contracts is viewed as a significant positive, sparking contrasting outlooks for the company's future.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is trending with a significant upward move, as the market appears to be finally re-rating the stock in light of its Breakthrough Therapy Designation for Pemvidutide and strong Phase 2 data published in The Lancet. Community discussions are heavily focused on the drug's 'best-in-class' potential for MASH and obesity, fueling intense speculation around a potential buyout or strategic partnership that would reflect a valuation comparable to sector peers.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as the community eagerly awaits the highly anticipated release of 3-year data from its pivotal EMBARK study for the Duchenne muscular dystrophy gene therapy, ELEVIDYS. Many are buzzing about the potential for significant stock action and a short squeeze, while others ponder the strategic implications of the company's pre-announcement, especially given ongoing discussions about its valuation and the critical need for effective DMD treatments.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG CRYPTO is trending as its "Infinite Money Glitch" protocol consistently delivers passive Solana rewards to holders directly, driven by trading volume. The highly engaged community highlights ongoing innovations, including new liquidity pools and a live audit platform, maintaining strong conviction in its long-term vision and utility despite market fluctuations. Discussions also center on its approaching one-year anniversary and potential for significant growth in the broader crypto ecosystem.

Equipmentshare.Com Inc - Ordinary Shares - Class A

EquipmentShare.com Inc 

EquipmentShare (EQPT) is trending following a successful market debut for its construction rental platform, which saw strong investor confidence. The community is actively discussing the company's significant momentum, with many expressing FOMO and anticipating continued growth fueled by its T3 technology and national scale. Investors are positioning for potential long-term value, comparing it to other successful market disruptors.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

FOX Crypto is trending with its community expressing high conviction for an imminent breakout, driven by its perceived undervaluation with a low market cap and status as a true DeFi project compared to platforms like Uniswap. Many anticipate substantial gains as "alt season" and a broader "super cycle" are widely discussed to be on the horizon for the crypto market.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is generating significant buzz as investors eagerly await an imminent FDA decision on an Afrezza label update, aimed at simplifying dosing and potentially boosting adoption following recent reports of strong quarterly revenue. Despite this anticipation, widespread community skepticism persists regarding past stock performance and management's effectiveness, fueling lively debate and comparisons with other rapidly growing biotech companies.

Global X Funds - Global X Copper Miners ETF

Global X Copper Miners ETF ($COPX) is trending strongly amid escalating geopolitical tensions and growing concerns over a persistent global supply deficit for copper. The community widely views copper as the "new oil," essential for AI, electrification, and infrastructure, driving bullish sentiment and active buying on dips in anticipation of significantly higher prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akso Health Group (NASDAQ:AHG) Shares Gap Up - Still a Buy?

Akso Health Group (NASDAQ:AHG) Shares Gap Up - Here's What Happened...

Akso Health Group (NASDAQ:AHG) Shares Down 5.4% - Here's What Happened

Akso Health Group (NASDAQ:AHG) Trading Down 5.4% - Here's Why...

Akso Health Group (NASDAQ:AHG) Shares Gap Down - Here's What Happened

Akso Health Group (NASDAQ:AHG) Shares Gap Down - What's Next...

Akso Health Group (NASDAQ:AHG) Sees Unusually-High Trading Volume - Here's What Happened

Akso Health Group (NASDAQ:AHG) Sees Unusually-High Trading Volume - Here's Why...

Akso Health Group (NASDAQ:AHG) Shares Up 8.6% - What's Next?

Akso Health Group (NASDAQ:AHG) Trading Up 8.6% - Here's What Happened...

Akso Health Group (NASDAQ:AHG) Shares Gap Up - Time to Buy?

Akso Health Group (NASDAQ:AHG) Shares Gap Up - Still a Buy...

Akso Health Group (NASDAQ:AHG) Shares Gap Down - Here's Why

Akso Health Group (NASDAQ:AHG) Shares Gap Down - Here's Why...

Akso Health Group (NASDAQ:AHG) Shares Down 3.7% - What's Next?

Akso Health Group (NASDAQ:AHG) Trading Down 3.7% - What's Next...

Akso Health Group (NASDAQ:AHG) Shares Gap Down - Should You Sell...

Akso Health Group (NASDAQ:AHG) Trading 3.2% Higher - Still a Buy?

Akso Health Group (NASDAQ:AHG) Trading Up 3.2% - Should You Buy...

Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.

Akso Health Group - ADR

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$1.51
Prev Close	$1.53
Open	$1.60
Dividend Yield	0.00%
50-Day Moving Average	$1.44
Beta	1.08
Avg. Volume	18,447.73
PE Ratio	-3.22

52-Week High	$2.10
52-Week Low	$0.831
Market Capitalization	$841.59M
EPS (Annual)	-$0.474
Price to Book	4.23
Revenue Per Employee	$547,973.89
Enterprise Value/EBITDA	N/A

AHG
Akso Health Group - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest AHG News

AHGAkso Health Group - ADR